Literature DB >> 12493019

Histopathology of portal hypertension: a practical guideline.

T Roskams1, A Baptista, L Bianchi, A Burt, F Callea, H Denk, J De Groote, V Desmet, S Hubscher, K Ishak, R MacSween, B Portmann, H Poulson, P Scheuer, L Terracciano, H Thaler.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12493019     DOI： 10.1046/j.1365-2559.2003.01464.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  10 in total

1.  Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.

Authors:  C E Eapen; Peter Nightingale; Stefan G Hubscher; Peter J Lane; Timothy Plant; Dimitris Velissaris; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

2.  Congenital malformations of the suprahepatic inferior vena cava: an easily overlooked etiology of chronic liver disease with tumor-like nodules.

Authors:  Giovanna Borghi-Scoazec; Pierre Rocca-Zanella; Pierre-Jean Valette; Didier Revel; Olivier Boillot; Christian Trepo; Jean-Yves Scoazec
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

3.  Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis.

Authors:  Natalia Rush; Hongliu Sun; Yukihiro Nakanishi; Wadad Mneimneh; Paul Y Kwo; Romil Saxena
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

4.  An association of myeloproliferative neoplasms and obliterative portal venopathy.

Authors:  Jillian E Mayer; Thomas D Schiano; Maria Isabel Fiel; Ronald Hoffman; John O Mascarenhas
Journal:  Dig Dis Sci       Date:  2014-01-29       Impact factor: 3.199

Review 5.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

6.  Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.

Authors:  Chunlai Zuo; Vaibhav Chumbalkar; Peter F Ells; Daniel J Bonville; Hwajeong Lee
Journal:  Hepatol Int       Date:  2017-06-08       Impact factor: 6.047

7.  Assessment of liver fibrosis in the early stages with perfusion CT.

Authors:  Liuhong Wang; Jingjing Fan; Xinfa Ding; Jianzhong Sun; Minming Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital.

Authors:  Kadiyala Madhu; Balekuduru Avinash; Banumathi Ramakrishna; C E Eapen; N K Shyamkumar; Uday Zachariah; George Chandy; George Kurian
Journal:  Indian J Gastroenterol       Date:  2009-11-12

9.  Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.

Authors:  Rajeshwar P Mookerjee; Gautam Mehta; Vairappan Balasubramaniyan; Fatma El Zahraa Mohamed; Nathan Davies; Vikram Sharma; Yasuko Iwakiri; Rajiv Jalan
Journal:  J Hepatol       Date:  2014-08-23       Impact factor: 25.083

10.  Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease?

Authors:  C Lemaitre; S Dominique; E Billoud; M Eliezer; H Montialoux; M Quillard; G Riachi; E Koning; H Morisse-Pradier; G Savoye; C Savoye-Collet; O Goria
Journal:  Can Respir J       Date:  2016-06-26       Impact factor: 2.409
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.